Popular weight loss drugs remain out of reach for many who need ...

Weight loss drugs like Wegovy and Zepbound have been hailed as a revolution. Yet the high cost and lack of insurance coverage make them ...

... and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions of older Americans.

The drug companies behind blockbuster weight loss and diabetes treatments have ... Patients taking the drugs reach out to him every week to ...

One of the biggest health stories of this past year is the surge in demand for popular weight-loss drugs like Ozempic and Wegovy.

Some patients have been successful on powerful new drugs for weight loss, but then they lose access to them because insurance won't cover ...

They're not meant for everyone. People have figured out how to get the drugs anyway. ... The new weight loss medications are approved by the Food ...

They're available compounded for significantly less than the brand name meds right now due to shortages actually.

The problem is daunting: Powerful but expensive new drugs could help many of the 100 million American adults who have obesity and alleviate ...

CNN Exclusive: Older weight loss drugs are making a comeback as Zepbound, Wegovy remain out of reach for many.

Only one in four U.S. patients prescribed Novo Nordisk's Wegovy or Ozempic for weight loss were still taking the popular medications two ...

Popular weight loss drugs remain out of reach for many who need them · Eli Lilly's weight loss drug Zepbound found to reduce sleep apnea, company ...

As medications like Ozempic, Wegovy and Mounjaro used by some for weight loss experience a surge in popularity, they remain out of reach for ...

Prescription weight loss medicines, like Ozempic, are helping people lose as much as 20% of their body weight. They're providing results—and ...

A recent report found that just 32% of people on GLP-1 drugs like Ozempic and Wegovy remain on the drugs after a year.

In fact, according to one pharmaceutical company, as many as 25,000 people are starting their new weight loss drug every week. But we've ...

Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. They are the medications that have revolutionized ...

But extraordinary demand, and high prices, for these drugs will keep them out of reach in the coming year for many patients who are likely to ...

... popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. The poll finds 12% of ...

Those aged between 18 and 34 years were less likely to stay on the weight loss medications and those who had the highest barriers to care were ...

Amid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and Zepbound, one question has remained for users, ...